Drug intelligence / Profile preview

D-PLEX100 (PolyPid Ltd.)

Development stage
Unknown
Lead developer
PolyPid
Modality
Small Molecules
Administration
Implant
01

Overview

D-PLEX (also known as D-PLEX100) is a localized, long-acting antibiotic formulation developed by PolyPid for the prevention of surgical site infections (SSIs). It consists of the broad-spectrum tetracycline antibiotic doxycycline encapsulated within PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology. This matrix allows for the controlled, continuous release of high concentrations of doxycycline directly at the surgical site for up to 30 days, effectively eradicating bacteria while maintaining low systemic levels to minimize potential toxicity. D-PLEX is primarily being evaluated in Phase 3 clinical trials for the prevention of sternal wound infections following cardiac surgery and has also been investigated for the prevention of abdominal surgical site infections.

Brand names
D-PLEX
Other names
local extended-release doxycycline
02

Targets

Bacterial RibosomeMMP12 (Macrophage Metalloelastase)mt-SSU (Small mitochondrial ribosomal subunit)

Beyond the preview

Go deeper on D-PLEX100 (PolyPid Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-PLEX100 (PolyPid Ltd.).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call